GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
Fortunately, there are plenty of blue-chip stocks with yields that beat what investors can earn from broad-based bond funds. To sort the options, Barron’s used FactSet to screen for stocks in the S&P ...